fbpx Skip to main content

Member's Profile


11575 Sorrento Valley Rd Ste 210
San Diego,   California
United States
Medical Device & Diagnostic
Membership Info
Membership Type: Industry
Membership Since: 2016
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About BioFluidica
Medical Device & Diagnostic Company
BioFluidica is bringing to market a novel solution for Circulating Tumor Cell (CTC) analysis. CTCs are an exciting new cancer biomarker that can be secured from a simple blood draw and used to manage a variety of cancer-related diseases. CTCs can be used to determine a patient’s response to therapy, which therapy is best for a particular patient (personalized medicine) and disease recurrence. BioFluidica, with funding from the National Institutes of Health (National Cancer Institute) and a global diagnostic company (Roche), has developed a technology platform for processing whole blood and searching for CTCs with high recovery, throughput and purity creating new paradigms for CTC use in cancer disease management. With the high sensitivity of BioFluidica’s platform, the potential for early detection of cancer from a blood draw is possible.
Related News
No related news posted by this Member